Comparison of four commercial RT‐PCR diagnostic kits for COVID‐19 in China

We compared the sensitivity and specificity of four commercial coronavirus disease (COVID‐19) diagnostic kits using real‐time reverse transcription–polymerase chain reaction (RT‐PCR). Kits I‐IV approved by the State Drug Administration of China were selected, and the detection targets were ORF1ab ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Lingyu, Cui, Shujuan, Zhang, Daitao, Lin, Changying, Chen, Lijuan, Wang, Quanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843276/
https://www.ncbi.nlm.nih.gov/pubmed/33320386
http://dx.doi.org/10.1002/jcla.23605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843276/
https://www.ncbi.nlm.nih.gov/pubmed/33320386
http://dx.doi.org/10.1002/jcla.23605

Ejemplares similares